Drug Shortage Report for SOMAVERT
Report ID | 12119 |
Drug Identification Number | 02448858 |
Brand name | SOMAVERT |
Common or Proper name | Somavert |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | PEGVISOMANT |
Strength(s) | 30MG |
Dosage form(s) | KIT POWDER FOR SOLUTION |
Route of administration | SUBCUTANEOUS |
Packaging size | 1 x 1mL pre filled syringe |
ATC code | H01AX |
ATC description | ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2017-06-05 |
Estimated end date | 2017-06-12 |
Actual end date | 2017-06-12 |
Shortage status | Resolved |
Updated date | 2017-06-13 |
Company comments | Resolved June 12, 2017. Please note that Somavert is fully available for the following strengths: · 10mg SFDPO 1x1ml · 15mg SFDPO 1x1ml · 20mg SFDPO 1x1ml · 25mg SFDPO 1x1ml |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-06-06 | English | Compare |
v2 | 2017-06-06 | French | Compare |
v3 | 2017-06-13 | English | Compare |
v4 | 2017-06-13 | French | Compare |
Showing 1 to 4 of 4